TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

Abstract Background Stereotactic ablative body radiotherapy (SABR) is a non-invasive alternative to surgery to control primary renal cell cancer (RCC) in patients that are medically inoperable or at high-risk of post-surgical dialysis. The objective of the FASTRACK II clinical trial is to investigat...

Full description

Bibliographic Details
Main Authors: Shankar Siva, Brent Chesson, Mathias Bressel, David Pryor, Braden Higgs, Hayley M. Reynolds, Nicholas Hardcastle, Rebecca Montgomery, Ben Vanneste, Vincent Khoo, Jeremy Ruben, Eddie Lau, Michael S. Hofman, Richard De Abreu Lourenco, Swetha Sridharan, Nicholas R. Brook, Jarad Martin, Nathan Lawrentschuk, Tomas Kron, Farshad Foroudi
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Cancer
Subjects:
SBRT
SABR
RCC
Metastases
Kidney
Adrenal
Online Access:http://link.springer.com/article/10.1186/s12885-018-4916-2

Internet

http://link.springer.com/article/10.1186/s12885-018-4916-2

Similar Items